The Role of Hereditary Thrombophilia Testing in Management of First-Time Pulmonary Embolism
- 7 March 2024
- journal article
- research article
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 33 (4) , 533-537
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Executive SummaryChest, 2021
- Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysisBMJ, 2019
- Thrombophilia Testing and Venous ThrombosisNew England Journal of Medicine, 2017
- Thrombosis: A major contributor to global disease burdenThrombosis Research, 2014
- Sex difference in risk of recurrent venous thrombosis and the risk profile for a second eventJournal of Thrombosis and Haemostasis, 2010
- Long-term outcome of pulmonary embolismCurrent Opinion in Hematology, 2008
- Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosisJournal of Thrombosis and Haemostasis, 2008
- Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic EventsJAMA, 2005
- Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort studyThe Lancet, 2003
- Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 2000